Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results (Q34665233)
scientific article
Language:
Current Data About Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results
(P31) (Q13442814)
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

(P304) 785-789
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

(P407) (Q1860)

(P433) 8
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

(P478) 69
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

(P577) Wednesday, August 1, 2007
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

(P921) (Q42824440)

(Q8277)

(Q161238)

(P1433) (Q1161692)
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

(P1476) "Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results" (language: en)
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

(P2093) Rose JW
(P1545) 1
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

Burns JB
(P1545) 2
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

Bjorklund J
(P1545) 3
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

Klein J
(P1545) 4
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

Watt HE
(P1545) 5
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

Carlson NG
(P1545) 6
(P248)
(P698) 17709711
(P813) Thursday, August 3, 2017

other details
description scientific article

External Links
(P356) 10.1212/01.WNL.0000267662.41734.1F
(P698) 17709711
(P5875) 6129678